Meena M Archie, MD
Vascular Surgery · Bellflower
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 12 years
- University of California, Geffen School of Medicine, 2014
Offices
1 location · Bandb Medical Group Inc · 9 clinicians in this group
Hospitals listed: Lac/Harbor-UCLA Med Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Archie’s office at (562) 888-8961 to ask if they take your plan before you enroll.
California Medical Board record
Licence A142383 · Current
Licensed to practise in California · since 2016 · expires 2028-05-31 · David Geffen School of Medicine at UCLA.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Surgery - Vascular Surgery
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Lac/Harbor-UCLA Med CenterTorrance, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Los Angeles County Department of Health Services, which runs 4 hospitalsPatients rate it 2 of 5 · 61% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.4 (1.03 to 1.76), Jul 2022 – Jun 2024Worse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 6.19 (3.89 to 8.48) · 636 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.418, Oct 2024 – Sep 2025
See every measure and the patient survey for Lac/Harbor-UCLA Med Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 6 the same, 1 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.4 (1.03 to 1.76) | Worse | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 6.19 (3.89 to 8.48) · 636 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.418 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.72 (0.69 to 2.74) · 510 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 177.34 (124.5 to 230.19) · 54 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.6 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.8 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.6 · 110 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 15.3 · 73 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 1,305 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,023 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 3,035 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.25) · 189 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.16 (0.6 to 3.72) · 621 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 16.15 (7.82 to 24.48) · 207 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.39 (3.47 to 11.31) · 207 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.66 (1.17 to 4.15) · 134 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.69 (0 to 1.46) · 2,400 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.138 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.458 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.312 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.093 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.2 · 113 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23.1 · 190 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 1.6 · 134 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.2 · 122 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.4 · 162 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.4 (5 to 10.8) · 115 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.2 to 17.3) · 115 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 93 cases | None | Jul 2023 – Jun 2025 |
What patients said (1,594 patients answered, 15% of those asked)
| Cleanliness | 1 |
| Nurse communication | 1 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 53% |
| Nurses "always" communicated well | 68% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 60% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 64% |
| Nurses "always" listened carefully | 65% |
| Nurses "always" treated them with courtesy and respect | 75% |
| "Always" quiet at night | 30% |
| "YES", patients would definitely recommend the hospital | 61% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$2,947
Medicare paid this office $2,947 for 15 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of skin and tissue, 20.0 sq cm or less | 34 | 59 | 47 | 128 | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
15 Original Medicare patients in 2024. Average age 59 · 85 and older 0% · Health risk score 8.83. Sicker patients than 9 in 10 peers; the typical vascular surgery clinician is at 2.33.
Conditions among them: High blood pressure 75% · Diabetes 75% · Heart failure 75% · Chronic kidney disease 75%.
The office billed $10,512, Medicare allowed $3,897 and paid $2,947; for 18 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 15 | 18 | 59 | 8.83 | $10,512 | $2,947 |
| 2023 | 110 | 171 | 76 | 3.33 | $35,965 | $11,501 |
| 2022 | 554 | 1,382 | 75 | 2.84 | $801,021 | $279,905 |
| 2021 | 567 | 1,178 | 74 | 2.84 | $1,178,085 | $312,025 |
| 2020 | 470 | 1,193 | 75 | 3.12 | $703,657 | $181,204 |
| 2019 | 233 | 529 | 74 | 2.67 | $208,479 | $58,773 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Short return visit (20+ min) | 32 | $1,763 | $52 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 21 | $578 | $28 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 22 | $389 | $18 |
2022: 19 services
| Ultrasound of leg arteries or artery grafts | 81 | $19,119 | $225 |
| Short return visit (20+ min) | 142 | $17,279 | $76 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 88 | $15,004 | $165 |
| New patient visit (60+ min) | 62 | $11,335 | $183 |
| Ultrasound of both sides of head and neck blood flow | 66 | $10,843 | $155 |
| Complete ultrasound study of arm and leg arteries | 91 | $9,157 | $92 |
| Removal of skin and tissue, 20.0 sq cm or less | 30 | $6,433 | $50 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 39 | $4,602 | $102 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 32 | $4,434 | $134 |
| Ultrasound of hemodialysis access | 32 | $4,280 | $113 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,681 | $168 |
| Ultrasound of arm arteries or artery grafts | 13 | $2,382 | $183 |
| New patient visit (60+ min) | 15 | $2,214 | $148 |
| Short return visit (20+ min) | 19 | $1,765 | $57 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 55 | $1,618 | $28 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,333 | $61 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 57 | $1,080 | $18 |
| Ultrasonic guidance for blood vessel access | 11 | $471 | $36 |
| Ultrasound study of arm and leg arteries | 11 | $113 | $10 |
2021: 13 services
| Ultrasound study of arm or leg veins with compression and maneuvers | 93 | $16,746 | $176 |
| Ultrasound of leg arteries or artery grafts | 53 | $13,606 | $239 |
| New patient visit (60+ min) | 62 | $11,908 | $192 |
| Short return visit (20+ min) | 110 | $11,246 | $75 |
| Ultrasound of both sides of head and neck blood flow | 62 | $11,013 | $172 |
| Complete ultrasound study of arm and leg arteries | 71 | $7,522 | $96 |
| Ultrasound of hemodialysis access | 41 | $5,768 | $115 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 25 | $3,468 | $133 |
| Ultrasound of arm arteries or artery grafts | 18 | $3,453 | $192 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 29 | $3,300 | $106 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 87 | $2,559 | $29 |
| Removal of skin and tissue, 20.0 sq cm or less | 12 | $2,474 | $53 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 62 | $1,135 | $18 |
2020: 17 services
| Ultrasound of leg arteries or artery grafts | 71 | $17,446 | $224 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 89 | $15,032 | $169 |
| Short return visit (20+ min) | 104 | $10,915 | $58 |
| Ultrasound of both sides of head and neck blood flow | 55 | $9,880 | $173 |
| Complete ultrasound study of arm and leg arteries | 89 | $9,764 | $99 |
| New patient visit (60+ min) | 51 | $8,288 | $163 |
| Ultrasound of hemodialysis access | 29 | $4,394 | $126 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 14 | $3,448 | $246 |
| Removal of skin and tissue, 20.0 sq cm or less | 21 | $3,160 | $54 |
| Ultrasound of arm arteries or artery grafts | 16 | $3,077 | $192 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 25 | $3,050 | $105 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 18 | $2,748 | $145 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 73 | $2,200 | $30 |
| Long return visit (40+ min) | 16 | $1,670 | $104 |
| Review by radiologist of arm or leg artery image | 12 | $1,240 | $73 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 39 | $748 | $19 |
| Ultrasonic guidance for blood vessel access | 11 | $198 | $12 |
2019: 9 services
| Ultrasound of leg arteries or artery grafts | 34 | $7,855 | $231 |
| New patient visit (60+ min) | 34 | $6,055 | $178 |
| Ultrasound of both sides of head and neck blood flow | 35 | $6,037 | $172 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 35 | $5,806 | $166 |
| Complete ultrasound study of arm and leg arteries | 41 | $4,099 | $98 |
| Short return visit (20+ min) | 39 | $3,574 | $53 |
| Removal of skin and tissue, 20.0 sq cm or less | 12 | $1,781 | $52 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 29 | $875 | $29 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 23 | $420 | $18 |
Medicaid work
$3,127 in 2021
Medicaid paid $3,127 for 28 billed services this clinician did in 2021, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| EXTREMITY STUDY | 28 | $3,127 |
| 2021 | 28 | 1 | 15 | $3,127 |
| 2020 | 28 | 2 | 12 | $2,598 |
See the largest Medicaid services in earlier years
2020
| EXTREMITY STUDY | 12 | $2,076 |
| Short return visit (20+ min) | 16 | $522 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 23% of their 149 Part D prescriptions in 2022. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2023 | 49 | 18 | None | 49% | $21,019 |
| 2022 | 149 | 73 | 23% (34) | 36% | $47,393 |
| 2021 | 189 | 85 | 27% (50) | 24% | $29,417 |
| 2020 | 121 | 48 | 12% (15) | 36% | $24,242 |
| 2019 | 29 | 22 | 45% (13) | None | $3,446 |
| 2018 | 15 | 15 | 93% (14) | None | $66 |
| 2017 | 14 | 14 | 100% (14) | 0% | $79 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Eliquis | 18 | $16,208 | $900 |
| Clopidogrel | 19 | $294 | $15 |
2022: 4 drugs
| Eliquis | 39 | $33,053 | $848 |
| Clopidogrel | 30 | $488 | $16 |
| Hydrocodone-Acetaminophen | 30 | $109 | $4 |
| Lorazepam | 25 | $24 | $1 |
2021: 4 drugs
| Eliquis | 28 | $20,977 | $749 |
| Clopidogrel | 33 | $337 | $10 |
| Hydrocodone-Acetaminophen | 45 | $157 | $3 |
| Lorazepam | 44 | $44 | $1 |
2020: 4 drugs
| Eliquis | 28 | $16,833 | $601 |
| Santyl | 16 | $6,425 | $402 |
| Clopidogrel | 17 | $232 | $14 |
| Hydrocodone-Acetaminophen | 15 | $113 | $8 |
Money from drug and device companies
$691 in 2025
| 2025 | 11 | 12 | None | $691 |
| 2024 | 10 | 18 | None | $1,112 |
| 2023 | 12 | 29 | None | $1,189 |
| 2022 | 6 | 13 | None | $666 |
| 2021 | 10 | 21 | None | $896 |
| 2020 | 7 | 16 | None | $345 |
| 2019 | 9 | 16 | None | $961 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| InspireMD | Cguard Prime Carotid Stent System | $271 | 2 payments
|
| Bard Peripheral Vascular | Rotarexs 6 F X 135 Cm | $138 | 1 payment
|
| Medtronic | Endurant Iis | $61 | 1 payment
|
| Cagent Vascular | Serrantor | $52 | 1 payment
|
| Abbott Laboratories | Esprit | $28 | 1 payment
|
| Acera Surgical | Restrata Wound Matrix | $27 | 1 payment
|
See all 12 published payments
| AngioDynamics | Meals · 2025-11-07 | Auryon Laser System 100-120 Vac | $18 |
| Bolton Medical | Meals · 2025-10-29 | Treo Abdominal Stent-Graft System | $25 |
| InspireMD | Meals · 2025-10-29 | Cguard Prime Carotid Stent System | $196 |
| Medtronic | Meals · 2025-09-16 | Endurant Iis | $61 |
| InspireMD | Meals · 2025-09-16 | Cguard Prime Carotid Stent System | $75 |
| W. L. Gore & Associates | Meals · 2025-07-23 | Excluder Conformable Aaa Endoprosthesis With Active Control | $27 |
| Acera Surgical | Meals · 2025-05-15 | Restrata Wound Matrix | $27 |
| Laminate Medical Technologies | Meals · 2025-02-26 | Vasq | $21 |
| Bard Peripheral Vascular | Meals · 2025-02-25 | Rotarexs 6 F X 135 Cm | $138 |
| Abbott Laboratories | Meals · 2025-02-24 | Esprit | $28 |
| Cagent Vascular | Meals · 2025-02-07 | Serrantor | $52 |
| Balt USA | Meals · 2025-01-23 | Prestige Coil System | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,112
| Balt USA | Prestige Coil System | $554 | 4 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $164 | 1 payment
|
| Laminate Medical Technologies | Vasq External Support | $72 | 1 payment
|
| W. L. Gore & Associates | Gore Tag Thoracic Branch Endoprosthesis | $62 | 2 payments
|
| Medtronic | In.Pact Admiral | $59 | 2 payments
|
| Cook Medical | Cook | $57 | 2 payments
|
| Bolton Medical | Relay Thoracic Stent-Graft With Plus Delivery System | $43 | 1 payment
|
| Abbott Laboratories | Perclose Prostyle | $38 | 2 payments
|
| LeMaitre Vascular | Artegraft Vascular Graft | $34 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $28 | 1 payment
|
2023: $1,189
| Abbott Laboratories | Jeti | $263 | 14 payments
|
| W. L. Gore & Associates | Gore Tag Conformable Thoracic Endoprosthesis | $172 | 1 payment
|
| Silk Road Medical | Enroute Transcarotid Neuroprotection System | $152 | 1 payment
|
| Penumbra | Indigo System | $140 | 1 payment
|
| Medtronic | Endurant Iis | $135 | 3 payments
|
| Lifenet Health | Matracell Pulmonary Patch Graft | $133 | 1 payment
|
| Cook Medical | Zilver Ptx | $62 | 2 payments
|
| Integra LifeSciences | Integra | $45 | 2 payments
|
| Bolton Medical | Relay Thoracic Stent-Graft With Plus Delivery System | $29 | 1 payment
|
| Pfizer | Eliquis | $26 | 1 payment
|
| Kci USA | Prevena | $19 | 1 payment
|
| Smith+Nephew | Collagenase Santyl | $14 | 1 payment
|
2022: $666
| Medtronic | Endurant Iis | $279 | 4 payments
|
| Silk Road Medical | Enroute Transcarotid Stent | $258 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $64 | 3 payments
|
| Philips Electronics North America | (4067) Tack Endo Sys Btk | $28 | 1 payment
|
| Pfizer | Eliquis | $21 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $17 | 1 payment
|
2021: $896
| Medtronic | Hawkone | $261 | 3 payments
|
| Abbott Laboratories | Supera Peripheral Stent System | $176 | 2 payments
|
| Silk Road Medical | Enroute Transcarotid Neuroprotection System | $169 | 2 payments
|
| Boston Scientific | General Balloons | $62 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $60 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $52 | 4 payments
|
| Cook Medical | Cook | $41 | 2 payments
|
| W. L. Gore & Associates | Excluder Conformable Aaa Endoprosthesis With Active Control | $36 | 1 payment
|
| Smith+Nephew | Stravix | $23 | 1 payment
|
| Pfizer | Eliquis | $16 | 1 payment
|
2020: $345
| Smith+Nephew | Santyl | $95 | 6 payments
|
| Abbott Laboratories | Supera Peripheral Stent System | $86 | 2 payments
|
| Pfizer | Eliquis | $55 | 2 payments
|
| LeMaitre Vascular | Procol | $40 | 2 payments
|
| Boston Scientific | Jetstream | $32 | 2 payments
|
| Baxter Healthcare | Tisseel | $25 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $12 | 1 payment
|
2019: $961
| Medtronic Vascular | Valiant Captivia | $608 | 7 payments
|
| Penumbra | Indigo | $166 | 2 payments
|
| Philips Electronics North America | Turbo Elite | $62 | 1 payment
|
| Baxter Healthcare | Preveleak | $28 | 1 payment
|
| Endologix | Ovation | $28 | 1 payment
|
| Cardiovascular Systems | Peripheral Orbital Atherectomy System | $28 | 1 payment
|
| Abbott Laboratories | Supera Peripheral Stent System | $18 | 1 payment
|
| LeMaitre Vascular | Catheter | $12 | 1 payment
|
| Smith+Nephew | Santyl | $12 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 78.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1588083646
- Licence
- CA A142383California A142383: Current · expires 2028-05-31
- Trained
- University of California, Geffen School of Medicine, 2014 · 12 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2086S0129X (2086S0129X)
- Mailing address
- 1140 W La Veta Ave Ste 850, Orange, CA, 92868
- NPI first listed
- 2014-04-15
- NPI last updated
- 2024-09-30
- NPI record certified
- 2024-09-30
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 16506 Lakewood Blvd Ste 200, Bellflower, CA, 90706